4′-Hydroxywogonin

Synonyms: 8-Methoxyapigenin
4′-Hydroxywogonin(8-Methoxyapigenin)是一种可从 Scutellaria barbata、Verbena littoralis 等多种植物中分离得到的黄酮类化合物,通过 TAK1/IKK/NF-κB、MAPKs 和 PI3/AKT 信号通路发挥抗炎活性,通过干扰 PI3K/AKT 信号抑制血管生成,并可抑制细胞增殖和诱导细胞凋亡 (apoptosis)。
产品编号: MS-R63851 纯度: 98.22% CAS No.: 57096-02-3 分子式: C16H12O6 分子量: 300.26
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
询价
50mg
询价
询价

产品描述

4′-Hydroxywogonin(8-Methoxyapigenin)是一种可从 Scutellaria barbata、Verbena littoralis 等多种植物中分离得到的黄酮类化合物,通过 TAK1/IKK/NF-κB、MAPKs 和 PI3/AKT 信号通路发挥抗炎活性,通过干扰 PI3K/AKT 信号抑制血管生成,并可抑制细胞增殖和诱导细胞凋亡 (apoptosis)。

生物实验数据

生物活性 4′-Hydroxywogonin (8-Methoxyapigenin) is a flavonoid isolated from various plants including Scutellaria barbata and Verbena littoralis, exerts anti-inflammatory activity through the TAK1/IKK/NF-κB, MAPKs, and PI3/AKT signaling pathways, inhibits angiogenesis by interfering with PI3K/AKT signaling, and suppresses cell proliferation and induces apoptosis.
体外研究
(In Vitro)

4′-Hydroxywogonin (8-Methoxyapigenin; 0.5-15 μM; 0-24 h) has low cytotoxicity and inhibits NO and PGE2 production in LPS-stimulated RAW 264.7 macrophages by suppression of iNOS and COX-2 expression.
4′-Hydroxywogonin (0.5-15 μM; 1 and 12 h) suppresses LPS-induced expression of pro-inflammatory cytokines in RAW 264.7 macrophages and suppresses LPS-induced activation of NF-κB.
4′-Hydroxywogonin (0.5-15 μM; 1 h) suppresses LPS-induced degradation of IκB-α and activation of IKK and TAK and suppresses the phosphorylation of MAPK and AKTin in RAW 264.7 macrophages.
4′-Hydroxywogonin (0.5-15 μM; 24 h) inhibits ROS production in LPS-stimulated RAW 264.7 macrophages.
4′-Hydroxywogonin (0-10 μg/mL; 24 h) reduces the viability of SW620 cells in a concentration- and time-dependent manner and decreases the mRNA and protein expression of vascular endothelial growth factor-A (VEGF-A), the predominant pro-angiogenic cytokine in tumor angiogenesis.
4′-Hydroxywogonin (24 h; SUP-B15 and Jurkat cells) induces apoptosis and decreases the expression of C-MYC, BCL-2 and cleaved caspase 3.

Cell Viability Assay

Cell Line: RAW 264.7 macrophages
Concentration: 0.5, 5 and 15 μM
Incubation Time: 24 hours
Result: Had low cytotoxicity in RAW 264.7 macrophages.

Western Blot Analysis

Cell Line: RAW 264.7 macrophages
Concentration: 0.5, 5 and 15 μM
Incubation Time: 1 hours
Result: Attenuated the increase of iNOS and COX-2 mRNA expression induced by LPS in RAW 264.7 cells.

Western Blot Analysis

Cell Line: RAW 264.7 macrophages
Concentration: 0.5, 5 and 15 μM
Incubation Time: 1 and 12 hours
Result: Reduced TNF-α, IL-6 and IL-1β mRNA expression in a dose-dependent manner.
Inhibited LPS-induced p65 phosphorylation and nuclear translocation.

Western Blot Analysis

Cell Line: RAW 264.7 macrophages
Concentration: 0.5, 5 and 15 μM
Incubation Time: 1 hours
Result: Attenuated LPS induced IκB-α degradation.
Attenuated the phosphorylation of ERK1/2 and p38 in a dose-dependent manner.
Reduced the intensity of the TAK1/TAB1 band.

Western Blot Analysis

Cell Line: SW620 cells
Concentration: 0.1, 1, and 10 μg/mL
Incubation Time: 24 hours
Result: Downregulated VEGF-Aexpression in colorectal cancer cells and suppressed angiogenesis.
体内研究
(In Vivo)

4′-Hydroxywogonin (10 and 20 mg/kg; i.p.; male C57BL/6 mice) alleviates LPS-induced acute lung injury (ALI) in a mouse model.

Animal Model: Male C57BL/6 mice (6-8 weeks old; 20 g) with acute lung injury model
Dosage: 10 and 20 mg/kg
Administration: Intraperitoneal injection, 12 and 1 h before LPS treatment
Result: Had potential protective effects against inflammation in LPS induced ALI mice.
Attenuated the degree of leukocyte infiltration.
性状 固体
颜色 Brown to breen

化学信息

分子量 300.26
分子式 C16H12O6
CAS No. 57096-02-3
别名 8-Methoxyapigenin

储存&溶解度

储存方式

4°C, protect from light

*In solvent: -80°C, 6 months; -20°C, 1 month (protect from light)

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础